Patent 7741352 was granted and assigned to Neurosearch A/S on June, 2010 by the United States Patent and Trademark Office.
This invention relates to novel compounds useful as modulators of the KCNQ channel, to pharmaceutical compositions comprising these compounds, and to methods of treatment herewith.